2020-12-21,Keros Therapeutics Announces Addition to NASDAQ Biotechnology Index
2020-12-17,"Keros Therapeutics Appoints Mary Ann Gray, Ph.D., to its Board of Directors"
2020-12-09,Is KROS A Good Stock To Buy Now?
2020-12-08,"Boeing, Kratos To Build Skyborg Drones For Air Force Experiments"
2020-12-07,"Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its ALK2 Inhibitor Program, Including KER-047 Phase 1 Data, and KER-050 Preclinical Data, at the Virtual 62nd American Society of Hematology Annual Meeting and Exposition"
2020-11-17,Keros Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
2020-11-16,Keros Therapeutics to Present at the Jefferies Virtual London Healthcare Conference
2020-11-12,Keros Therapeutics Announces Pricing of Public Offering of Common Stock
2020-11-10,Keros Therapeutics Announces Proposed Public Offering of Common Stock
2020-11-10,Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results
2020-11-09,Global Health Sciences Fund (Quark Venture LP and GF Securities) Announces Portfolio Company SQZ Biotechnologies IPO
2020-11-04,Keros Therapeutics to Present at the Virtual 62nd American Society of Hematology Annual Meeting and Exposition
2020-10-27,"How Many Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Did Insiders Buy, In The Last Year?"
2020-10-20,"Keros Therapeutics, Inc. Announces Dosing of First Participants in Phase 2 Clinical Trial of KER-050 in Myelodysplastic Syndromes (MDS)"
2020-09-14,Keros Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
2020-09-11,Keros Therapeutics Presents Results from Preclinical Studies Investigating KER-012 at the American Society for Bone and Mineral Research 2020 Annual Meeting
2020-08-13,Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results
2020-08-10,"Keros Therapeutics to be Featured on The Balancing Act's ""Behind the Mystery"" Rare Disease Series"
2020-08-04,"Keros Therapeutics, Inc. Announces Completion of Dosing of Planned Cohorts in KER-047 Phase 1 Trial and Provides Program Update"
2020-07-29,Here's Why We're Not Too Worried About Keros Therapeutics' (NASDAQ:KROS) Cash Burn Situation
2020-06-26,Keros Therapeutics Set to Join Russell 2000Â® Index
2020-06-24,Keros Therapeutics (KROS) in Focus: Stock Moves 6.8% Higher
2020-06-12,"Keros Therapeutics Presents Results from Clinical and Preclinical Studies Investigating KER-050, along with Preclinical Data from its ALK2 Inhibitor Program, at the European Hematology Association 2020 Annual Meeting"
2020-05-28,Keros Therapeutics To Present At The Jefferies 2020 Virtual Healthcare Conference
2020-05-22,Keros Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results
2020-05-14,Keros Therapeutics to Present at the Virtual 25th Annual Congress of the European Hematology Association
2020-05-05,3 Biotech Stocks With Plenty of Upside in the Pipeline
2020-04-13,Keros Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
2020-04-07,Keros Therapeutics Announces Pricing of Initial Public Offering of Common Stock
